GlassScriptPhysician profile
Charles Whitley Emerson
NPI 1124224753
$888.78
in general payments reported to CMS, 2019-2025
18 companies · $65.22 in 2025
The $65.22 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.07 · 2021: $57.15 · 2022: $432 · 2023: $207 · 2024: $63.62 · 2025: $65.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $394.95 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $55.83 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $52.00 | 2022-2023 | Emgality, Jardiance |
| Shield Therapeutics INC | $50.43 | 2023 | Accrufer |
| Glaxosmithkline, LLC. | $39.61 | 2022-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $37.92 | 2022 | |
| Merck Sharp & Dohme LLC | $36.04 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.69 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $30.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.83 | 2022 | |
| Amgen INC. | $28.03 | 2019 | |
| Mylan Specialty L.P. | $19.29 | 2022 | |
| Antares Pharma, INC. | $19.07 | 2025 | Xyosted |
| Sanofi Pasteur INC. | $13.51 | 2023 | |
| Abbvie INC. | $13.26 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $12.41 | 2021 | |
| Intra-Sana Laboratories | $12.19 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Emerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.